MAPT and Alzheimer disease: In the worldwide effort to identify leverage points to delay the onset of Alzheimer’s disease (AD), sleep has emerged as a potent modifiable factor to slow down the characteristic pathophysiological processes of the disease, i.e., the accumulation of amyloid-beta (Aβ) and tau proteins, together with neurodegeneration [1].